Gilbert R. Kaufmann

4.4k total citations · 1 hit paper
46 papers, 3.4k citations indexed

About

Gilbert R. Kaufmann is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Gilbert R. Kaufmann has authored 46 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 32 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Gilbert R. Kaufmann's work include HIV Research and Treatment (32 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (20 papers). Gilbert R. Kaufmann is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (20 papers). Gilbert R. Kaufmann collaborates with scholars based in Australia, Switzerland and United States. Gilbert R. Kaufmann's co-authors include David A. Cooper, Andrew Carr, Anna Sesselja Þórisdóttir, Katherine Samaras, Donald J. Chisholm, Manuel Battegay, John Zaunders, Bernard Hirschel, Don Smith and Parham Sendi and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Gilbert R. Kaufmann

45 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

1999 1.2k citations Andrew Carr, Gilbert R. Kaufmann et al. profile →

Peers

Countries citing papers authored by Gilbert R. Kaufmann

Since Specialization

Citations

This map shows the geographic impact of Gilbert R. Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert R. Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert R. Kaufmann more than expected).

Fields of papers citing papers by Gilbert R. Kaufmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert R. Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert R. Kaufmann. The network helps show where Gilbert R. Kaufmann may publish in the future.

Co-authorship network of co-authors of Gilbert R. Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert R. Kaufmann. A scholar is included among the top collaborators of Gilbert R. Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert R. Kaufmann. Gilbert R. Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death 2011 ·AIDS ·Gilbert R. Kaufmann, Luigia Elzi, Rainer Weber, Hansjakob Furrer, Stefano Giulieri, Pietro Vernazza, Enos Bernasconi, Bernard Hirschel, Manuel Battegay	33
2	Open and hidden agendas of "asymptomatic" patients who request check-up exams 2011 ·BMC Family Practice ·Sabina Hunziker, Martin Schläpfer, Wolf Langewitz, Gilbert R. Kaufmann, Reto Nüesch, Edouard Battegay, Lukas Zimmerli	11
3	CD4 ⁺ T Cell Count Recovery in HIV Type 1–Infected Patients Is Independent of Class of Antiretroviral Therapy 2008 ·Clinical Infectious Diseases ·Nina Khanna, Milos Opravil, Hansjakob Furrer, Matthias Cavassini, Pietro Vernazza, Enos Bernasconi, Rainer Weber, Hans H. Hirsch, Manuel Battegay, Gilbert R. Kaufmann, (unknown)	34
4	Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy 2007 ·AIDS ·Angela Huttner, Gilbert R. Kaufmann, Manuel Battegay, Rainer Weber, Milos Opravil	28
5	Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy 2005 ·Clinical Infectious Diseases ·Gilbert R. Kaufmann, H Furrer, Bruno Ledergerber, Lionel Perrin, Milos Opravil, P Vernazza, Matthias Cavassini, Enos Bernasconi, Martin Rickenbach, Bernard Hirschel, M Battegay, (unknown)	245
6	Productivity costs and determinants of productivity in HIV-infected patients 2004 ·Clinical Therapeutics ·Parham Sendi, (unknown), Chaiwat Ungsedhapand, Gilbert R. Kaufmann, Heiner C. Bucher, Rainer Weber, Manuel Battegay	21
7	Immune Reconstitution in HIV‐Infected Patients 2004 ·Clinical Infectious Diseases ·Hans H. Hirsch, Gilbert R. Kaufmann, Parham Sendi, Manuel Battegay	232
8	Greater Reversal of CD4 ⁺ Cell Abnormalities and Viral Load Reduction after Initiation of Antiretroviral Therapy with Zidovudine, Lamivudine, and Nelfinavir before Complete HIV Type 1 Seroconversion 2003 ·AIDS Research and Human Retroviruses ·Don Smith, Gilbert R. Kaufmann, James O. Kahn, Frederick Hecht, (unknown), John Zaunders, Philip Cunningham, Andrew Carr, (unknown), (unknown), (unknown), David A. Cooper	11
9	Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection 2002 ·The Journal of Immunology ·Sharon R. Lewin, Ruy M. Ribeiro, Gilbert R. Kaufmann, Don Smith, John Zaunders, Matthew Law, Ajantha Solomon, Paul Cameron, David A. Cooper, Alan S. Perelson	42
10	The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy 2002 ·AIDS ·Gilbert R. Kaufmann, Mark Bloch, Robert Finlayson, John Zaunders, Don Smith, David A. Cooper	137
11	Relative Significance of Different Pathways of Immune Reconstitution in HIV Type 1 Infection as Estimated by Mathematical Modeling 2001 ·AIDS Research and Human Retroviruses ·Gilbert R. Kaufmann, John Zaunders, John M. Murray, Anthony D. Kelleher, Sharon R. Lewin, Ajantha Solomon, Don Smith, David A. Cooper	20
12	Novel Deletion of HIV Type 1 Reverse Transcriptase Residue 69 Conferring Selective High-Level Resistance to Nevirapine 2001 ·AIDS Research and Human Retroviruses ·Kazuo Suzuki, Gilbert R. Kaufmann, Motokazu Mukaide, Philip Cunningham, (unknown), (unknown), Makiko Kondo, (unknown), Sarah Pett, Robert Finlayson, John Zaunders, Anthony D. Kelleher, David A. Cooper	9
13	Impact of HIV Type 1 Protease, Reverse Transcriptase, Cleavage Site, and p6 Mutations on the Virological Response to Quadruple Therapy with Saquinavir, Ritonavir, and Two Nucleoside Analogs 2001 ·AIDS Research and Human Retroviruses ·Gilbert R. Kaufmann, Kazuo Suzuki, Philip Cunningham, Motokazu Mukaide, Makiko Kondo, (unknown), John Zaunders, David A. Cooper	30
14	Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection 2000 ·AIDS ·Gilbert R. Kaufmann, John Zaunders, Philip Cunningham, Anthony D. Kelleher, (unknown), Don Smith, Andrew Carr, (unknown)	80
15	Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV‐1 DNA Despite Clearance of Plasma Viremia 1999 ·The Journal of Infectious Diseases ·John Zaunders, Philip Cunningham, Anthony D. Kelleher, Gilbert R. Kaufmann, (unknown), (unknown), (unknown), (unknown), Jeanette Vizzard, Andrew Carr, David A. Cooper	100
16	Phenotypic Analysis of CD8+ T Lymphocytes in a Cohort of HIV Type 1-Infected Patients Treated with Saquinavir, Ritonavir, and Two Nucleoside Analogs for 1 Year, and Association with Plasma HIV Type 1 RNA 1999 ·AIDS Research and Human Retroviruses ·Gilbert R. Kaufmann, John Zaunders, Philip Cunningham, David A. Cooper	18
17	Primary HIV-1 Infection: A Review of Clinical Manifestations, Immunologic and Virologic Changes 1998 ·AIDS Patient Care and STDs ·Gilbert R. Kaufmann, Chris Duncombe, John Zaunders, Philip Cunningham, D.N. Cooper	15
18	Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals 1998 ·AIDS ·Gilbert R. Kaufmann, Chris Duncombe, Philip Cunningham, Alexander Beveridge, Andrew Carr, D. Sayer, Martyn A. French, David A. Cooper	43
19	Patterns of Viral Dynamics during Primary Human Immunodeficiency Virus Type 1 Infection 1998 ·The Journal of Infectious Diseases ·Gilbert R. Kaufmann, Philip Cunningham, Anthony D. Kelleher, John Zaunders, Andrew Carr, Jeanette Vizzard, Matthew Law, (unknown), (unknown)	62
20	[Type 4 and 7a adenovirus infections in East Switzerland 1958; clinical, virological and serological studies]. 1959 ·PubMed ·Gilbert R. Kaufmann, T Wegmann, Markus Rentsch, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact